SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001347613-18-000032
Filing Date
2018-11-09
Accepted
2018-11-09 09:06:13
Documents
66
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgyp-20180930.htm   iXBRL 10-Q 1105750
2 EXHIBIT 10.1 separationagreementmar.htm EX-10.1 78956
3 EXHIBIT 10.2 a12454925v6tax-synergy.htm EX-10.2 86073
4 EXHIBIT 10.3 synergy-luoxinagreemen.htm EX-10.3 926243
5 EXHIBIT 31.1 sgyp-ex311x93018x10q.htm EX-31.1 12863
6 EXHIBIT 31.2 sgyp-ex312x93018x10q.htm EX-31.2 12944
7 EXHIBIT 32.1 sgyp-ex321x93018x10q.htm EX-32.1 7222
8 EXHIBIT 32.2 sgyp-ex322x93018x10q.htm EX-32.2 7773
  Complete submission text file 0001347613-18-000032.txt   6495253

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20180930.xsd EX-101.SCH 37561
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20180930_cal.xml EX-101.CAL 65275
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20180930_def.xml EX-101.DEF 253603
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgyp-20180930_lab.xml EX-101.LAB 473970
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20180930_pre.xml EX-101.PRE 356513
14 EXTRACTED XBRL INSTANCE DOCUMENT sgyp-20180930_htm.xml XML 759365
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 181171545
SIC: 2834 Pharmaceutical Preparations